Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Non-Current Deffered Revenue (2019 - 2025)

AVITA Medical filings provide 7 years of Non-Current Deffered Revenue readings, the most recent being $290000.0 for Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue fell 10.49% to $290000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $290000.0, a 10.49% decrease, with the full-year FY2025 number at $290000.0, down 10.49% from a year prior.
  • Non-Current Deffered Revenue hit $290000.0 in Q4 2025 for AVITA Medical, down from $298000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $1.1 million in Q2 2021 to a low of $290000.0 in Q4 2025.
  • Median Non-Current Deffered Revenue over the past 5 years was $369500.0 (2023), compared with a mean of $559600.0.
  • Biggest five-year swings in Non-Current Deffered Revenue: surged 147.13% in 2021 and later tumbled 56.69% in 2023.
  • AVITA Medical's Non-Current Deffered Revenue stood at $952000.0 in 2021, then dropped by 26.68% to $698000.0 in 2022, then crashed by 48.85% to $357000.0 in 2023, then decreased by 9.24% to $324000.0 in 2024, then fell by 10.49% to $290000.0 in 2025.
  • The last three reported values for Non-Current Deffered Revenue were $290000.0 (Q4 2025), $298000.0 (Q3 2025), and $307000.0 (Q2 2025) per Business Quant data.